- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/82 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins
Patent holdings for IPC class G01N 33/82
Total number of patents in this class: 420
10-year publication summary
29
|
47
|
46
|
35
|
33
|
24
|
33
|
33
|
32
|
10
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Quest Diagnostics Investments Incorporated | 432 |
43 |
Siemens Healthcare Diagnostics Inc. | 1946 |
17 |
Roche Diagnostics Operations, Inc. | 1375 |
12 |
F. Hoffmann-La Roche AG | 7958 |
11 |
bioMerieux | 917 |
10 |
Immundiagnostik AG | 129 |
9 |
Labrador Diagnostics LLC | 287 |
9 |
Société des Produits Nestlé S.A. | 9672 |
8 |
Future Diagnostics B.V. | 8 |
8 |
Roche Diagnostics GmbH | 2745 |
7 |
Abbott Laboratories | 2542 |
6 |
Charles Sturt University | 22 |
6 |
Eisai R&D Management Co., Ltd. | 1304 |
6 |
Mayo Foundation for Medical Education and Research | 2981 |
5 |
JEOL Ltd. | 556 |
5 |
DiaSorin Italia S.p.A | 45 |
5 |
DSM IP Assets B.V. | 5856 |
4 |
Cohesive Technologies, Inc. | 15 |
4 |
Purdue Research Foundation | 3277 |
4 |
Enzo Life Sciences, Inc. | 174 |
4 |
Other owners | 237 |